Search Results - "HARTOG, Jasper W. L"

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome by Willemsen, Suzan, Hartog, Jasper W. L., Heiner-Fokkema, M. Rebecca, van Veldhuisen, Dirk J., Voors, Adriaan A.

“…The prevalence of heart failure (HF) is increasing. A distinction is made between diastolic HF (preserved left ventricular ejection fraction (LVEF)) and…”
Get full text

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction by Willemsen, Suzan, MD, PhD, Hartog, Jasper W.L., MD, PhD, van Veldhuisen, Dirk J., MD, PhD, van der Meer, Peter, MD, PhD, Roze, Joline F., BSc, Jaarsma, Tiny, PhD, Schalkwijk, Casper, PhD, van der Horst, Iwan C.C., MD, PhD, Hillege, Hans L., MD, PhD, Voors, Adriaan A., MD, PhD

“…Introduction Advanced glycation end products (AGEs) are increased in patients with heart failure (HF). We studied the predictive value of plasma AGEs Nε…”
Get full text

Clinical and prognostic value of advanced glycation end-products in chronic heart failure by Hartog, Jasper W.L., Voors, Adriaan A., Schalkwijk, Casper G., Scheijen, Jean, Smilde, Tom D.J., Damman, Kevin, Bakker, Stephan J.L., Smit, Andries J., van Veldhuisen, Dirk J.

“…Aims Advanced glycation end-products (AGEs) have been proposed as a novel factor involved in the development and progression of chronic heart failure (CHF). We…”
Get full text

Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients by Hartog, Jasper W. L., de Vries, Aiko P. J., Bakker, Stephan J. L., Graaff, Reindert, van Son, Willem J., van der Heide, Jaap J. Homan, Gans, Reinold O. B., Wolffenbuttel, Bruce H. R., de Jong, Paul E., Smit, Andries J.

“…Background. Accumulation of advanced glycation end-products (AGEs) has been implicated in the pathogenesis of chronic transplant dysfunction and cardiovascular…”
Get full text

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction by Voors, Adriaan A., van de Wal, Ruud M., L Hartog, Jasper W., Vijn, Richard G., Hummel, Yoran M., Plokker, Thijs W. M., van Veldhuisen, Dirk J., Jaarsma, Wybren

“…Objective To compare the effects of an angiotensin receptor blocker(ARB)-based regimen versus a non-ARB based regimen on diastolic function and neurohormones…”
Get full text

Functional and Hemodynamic Cardiac Determinants of Exercise Capacity in Patients With Systolic Heart Failure by Hummel, Yoran M., BSc, Bugatti, Silvia, MD, Damman, Kevin, MD, PhD, Willemsen, Suzan, MD, PhD, Hartog, Jasper W.L., MD, PhD, Metra, Marco, MD, PhD, Sipkens, Johannes S., MD, van Veldhuisen, Dirk J., MD, PhD, Voors, Adriaan A., MD, PhD

“…Decreased exercise capacity is the main symptom in patients with heart failure (HF). We assessed the association among noninvasively determined maximal cardiac…”
Get full text

Advanced glycation end-products (AGEs) and heart failure: Pathophysiology and clinical implications by Hartog, Jasper W.L., Voors, Adriaan A., Bakker, Stephan J.L., Smit, Andries J., van Veldhuisen, Dirk J.

“…Advanced glycation end-products (AGEs) are molecules formed during a non-enzymatic reaction between proteins and sugar residues, called the Maillard reaction…”
Get full text

Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure by Hartog, Jasper W.L., Willemsen, Suzan, van Veldhuisen, Dirk J., Posma, Jan L., van Wijk, Leen M., Hummel, Yoran M., Hillege, Hans L., Voors, Adriaan A.

“…Aims Advanced glycation endproducts (AGEs) have been associated with the development and progression of chronic heart failure (CHF). Advanced glycation…”
Get full text

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients by MEERWALDT, Robbert, HARTOG, Jasper W. L, SMIT, Andries J, GRAAFF, Reindert, HUISMAN, Roel J, LINKS, Thera P, DEN HOLLANDER, Nynke C, THORPE, Susan R, BAYNES, John W, NAVIS, Gerjan, GANS, Rijk O. B

“…Tissue advanced glycation end products (AGE) are a measure of cumulative metabolic stress and trigger cytokines driven inflammatory reactions. AGE are thought…”
Get full text

Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients by Willemsen, Suzan, Hartog, Jasper W.L., Hummel, Yoran M., van Ruijven, Marieke H.I., van der Horst, Iwan C.C., van Veldhuisen, Dirk J., Voors, Adriaan A.

“…Aims Advanced glycation end products (AGEs) are increased in patients with diabetes and are associated with diastolic dysfunction through the formation of…”
Get full text

Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial by Willemsen, Suzan, Hartog, Jasper W.L., Hummel, Yoran M., Posma, Jan L., van Wijk, Leen M., van Veldhuisen, Dirk J., Voors, Adriaan A.

“…Aims Previous small open label studies have shown that the advanced glycation end-product (AGE) breaker alagebrium may improve cardiac function in patients…”
Get full text

Advanced Glycation Endproducts in Chronic Heart Failure by Smit, Andries J., Hartog, Jasper W. L., Voors, Adriaan A., Van Veldhuisen, Dirk J.

“…Advanced glycation endproducts (AGEs) have been proposed as factors involved in the development and progression of chronic heart failure (CHF). Cross‐linking…”
Get full text

Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal Disease by HARTOG, JASPER W. L., DE VRIES, AIKO P. J., LUTGERS, HELEN L., MEERWALDT, ROBBERT, HUISMAN, ROEL M., VAN SON, WILLEM J., DE JONG, PAUL E., SMIT, ANDRIES J.

“…: Advanced glycation end products (AGEs) accumulate during renal failure and dialysis. Kidney transplantation is thought to reverse this accumulation by…”
Get full text

Skin-Autofluorescence Is an Independent Predictor of Graft Loss in Renal Transplant Recipients by HARTOG, Jasper W. L, GROSS, Sascha, BIERHAUS, Angelika, BAKKER, Stephan J. L, OTERDOOM, Leendert H, VAN REE, Rutger M, DE VRIES, Aiko P. J, SMIT, Andries J, SCHOUTEN, Jan P, NAWROTH, Peter P, GANS, Reinold O. B, VAN SON, Willem J

Get full text

Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction by Hartog, Jasper W.L., van de Wal, Ruud M., Schalkwijk, Casper G., Miyata, Toshio, Jaarsma, Wybren, Plokker, H.W. Thijs, van Wijk, Leen M., Smit, Andries J., van Veldhuisen, Dirk J., Voors, Adriaan A.

“…Aims To investigate the relationship between advanced glycation end‐products (AGEs) and diastolic function and the response to blood pressure treatment in…”
Get full text

Skin-Autofluorescence, a Measure of Tissue Advanced Glycation End-Products (AGEs), is Related to Diastolic Function in Dialysis Patients by Hartog, Jasper W.L., MD, Hummel, Yoran M., BSc, Voors, Adriaan A., MD, PhD, Schalkwijk, Casper G., PhD, Miyata, Toshio, MD, PhD, Huisman, Roel M., MD, PhD, Smit, Andries J., MD, PhD, Van Veldhuisen, Dirk J., MD, PhD

“…Abstract Background Diastolic dysfunction is a frequent cause of heart failure, particularly in dialysis patients. Advanced glycation endproducts (AGEs) are…”
Get full text

Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines" by Hartog, Jasper W L, Willemsen, Suzan, Voors, Adriaan A

Get full text

Skin-autofluorescence is an independent predictor of graft loss in renal transplant recipients by Hartog, Jasper W L, Gross, Sascha, Oterdoom, Leendert H, van Ree, Rutger M, de Vries, Aiko P J, Smit, Andries J, Schouten, Jan P, Nawroth, Peter P, Gans, Reinold O B, van Son, Willem J, Bierhaus, Angelika, Bakker, Stephan J L

“…Skin-autofluorescence (skin-AF) noninvasively measures the tissue accumulation of advanced glycation end products (AGEs). AGEs are nephrotoxic and potential…”
Get full text

What is the Influence of Renal Function on the Prognostic Value of Advanced Glycation End-Products and sRAGE in Heart Failure? by Hartog, Jasper W.L, Willemsen, Suzan, Voors, Adriaan A

Get full text

Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction by Hartog, Jasper W.L, Smit, Andries J, van Son, Willem J, Navis, Gerjan, Gans, Reinold O.B, Wolffenbuttel, Bruce H.R, de Jong, Paul E

“…Chronic renal transplant dysfunction is one of the leading causes of graft failure in kidney transplantation. A complex interplay of both alloantigen-related…”
Get full text